|
|
Volumn 175, Issue 9, 2001, Pages 486-489
|
|
Statin-associated myopathy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFUNGAL AGENT;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BEZAFIBRATE;
CERIVASTATIN;
CLARITHROMYCIN;
CREATINE KINASE;
CYCLOSPORIN;
CYTOCHROME P450 3A4;
CYTOCHROME P450 INHIBITOR;
DILTIAZEM;
ERYTHROMYCIN;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
GEMFIBROZIL;
ITRACONAZOLE;
KETOCONAZOLE;
MEVINOLIN;
NEFAZODONE;
NICOTINIC ACID;
OMEGA 3 FATTY ACID;
PRAVASTATIN;
PROTEINASE INHIBITOR;
SIMVASTATIN;
VERAPAMIL;
CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
DIET SUPPLEMENTATION;
DIFFERENTIAL DIAGNOSIS;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FRUIT JUICE;
HUMAN;
HYPERLIPIDEMIA;
HYPOTHYROIDISM;
INCIDENCE;
INJURY;
MUSCLE WEAKNESS;
MYALGIA;
MYOPATHY;
MYOSITIS;
PAIN;
PATIENT MONITORING;
PHYSICAL CHEMISTRY;
POSTMARKETING SURVEILLANCE;
PREVALENCE;
REVIEW;
RHABDOMYOLYSIS;
RISK FACTOR;
SURGICAL RISK;
TOXICITY;
VIRUS INFECTION;
|
|
EID: 0035813319
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2001.tb143683.x Document Type: Review |
|
Times cited : (113)
|
|
References (16)
|
